It was concluded that ABT-414 is well tolerated as infusion was only associated with modest elevation in glial fibrillary acidic protein (GFAP) without loss of NeuN staining or increased infiltration of CD68-positive cells and resulted in extended survival in orthotopic GBM PDXs. Here, GFAP is linked to glioblastoma.